Canada’s Drug Agency | Drugs, Health Technologies and Systems.

olaparib

Details

Files
Generic Name:
olaparib
Project Status:
Active
Therapeutic Area:
Pancreatic cancer
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
PX0382-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Submission Complexity:
Standard Review
Fee Schedule:
Pending
Key Milestones2
Submission received30-Jun-25

Files

Proposed Scope View PDF
Last Updated : July 17, 2025